Latest news
Loading news…
Human Genome Sciences is a biopharmaceutical research company that develops drugs based on human genomic information.
Human Genome Sciences was acquired by GlaxoSmithKline in 2012 for $3B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Investments
1
Monthly Visits
Available in Pro Contacts
134
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 6
- IT spend
- $8.82M
Investor Activity
- Investments
- 1
- Portfolio orgs
- 1
Company Info
- Org types
- company, investor
- HQ
- Rockville, Maryland, United States
Signals & Scores
- Trend (7d)
- -0.1
- Trend (30d)
- 0.9
- Trend (90d)
- 2.3
Investments by Human Genome Sciences
Loading columns…
0 of 0Show
Page 1 / 1
134
professional contacts at Human Genome Sciences
Contact execs at Human Genome Sciences →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Human Genome Sciences
Loading news…
FAQs about Human Genome Sciences
People who checked this page also checked these
Browse the full Acquirezy directory.